List of works by Mark Clemons

A Phase 2 study of perifosine in advanced or metastatic breast cancer.

scientific article published on 26 April 2007

A Phase II trial evaluating the palliative benefit of second-line oral ibandronate in breast cancer patients with either a skeletal related event (SRE) or progressive bone metastases (BM) despite standard bisphosphonate (BP) therapy

scientific article published on 02 May 2007

A Systematic Review of the Incidence and Risk Factors for Taxane Acute Pain Syndrome in Patients Receiving Taxane-Based Chemotherapy for Prostate Cancer

scientific article

A Uridine Glucuronosyltransferase 2B7 Polymorphism Predicts Epirubicin Clearance and Outcomes in Early-Stage Breast Cancer.

scientific article published on 25 September 2015

A cost-utility analysis of risk model-guided versus physician's choice antiemetic prophylaxis in patients receiving chemotherapy for early-stage breast cancer: a net benefit regression approach.

scientific article

A multi-center pragmatic, randomized, feasibility trial comparing standard of care schedules of filgrastim administration for primary febrile neutropenia prophylaxis in early-stage breast cancer.

scientific article

A multi-centre, randomised trial comparing schedules of G-CSF (filgrastim) administration for primary prophylaxis of chemotherapy-induced febrile neutropenia in early stage breast cancer

scientific article published on 20 April 2020

A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy

scientific article published on 07 August 2019

A national portfolio of bone oncology trials-The Canadian experience in 2012.

scientific article

A phase 2 trial exploring the clinical and correlative effects of combining doxycycline with bone-targeted therapy in patients with metastatic breast cancer.

scientific article published on July 2016

A phase 2 trial exploring the effects of high-dose (10,000 IU/day) vitamin D(3) in breast cancer patients with bone metastases

scientific article published in January 2010

A phase I/II trial of epirubicin and docetaxel in locally advanced breast cancer (LABC) on 2-weekly or 3-weekly schedules: NCIC CTG MA.22.

scientific article

A phase II study of pazopanib in patients with recurrent or metastatic invasive breast carcinoma: a trial of the Princess Margaret Hospital phase II consortium

scientific article published on 3 August 2010

A phase II, multicentre trial evaluating the efficacy of de-escalated bisphosphonate therapy in metastatic breast cancer patients at low-risk of skeletal-related events.

scientific article published on 18 March 2014

A primer of bone metastases management in breast cancer patients

scientific article

A prospective intervention to improve happiness and reduce burnout in oncologists

scientific article published on 30 November 2018

A randomised trial of 4- versus 12-weekly administration of bone-targeted agents in patients with bone metastases from breast or castration-resistant prostate cancer

scientific article published on 03 October 2020

A randomised, placebo-controlled, double-blind trial of the effects of d-methylphenidate on fatigue and cognitive dysfunction in women undergoing adjuvant chemotherapy for breast cancer

scientific article published on 31 October 2007

A randomized clinical trial comparing physician-directed or fixed-dose steroid replacement strategies for incomplete dexamethasone dosing prior to docetaxel chemotherapy

scientific article published on 15 October 2020

A randomized clinical trial of adjuvant chemotherapy for radically resected locoregional relapse of breast cancer: IBCSG 27-02, BIG 1-02, and NSABP B-37.

scientific article published in June 2008

A randomized double-blind placebo-controlled cross-over trial of the impact on quality of life of continuing dexamethasone beyond 24 h following adjuvant chemotherapy for breast cancer

scientific article published on 6 September 2012

A randomized phase II study of weekly paclitaxel with or without pelareorep in patients with metastatic breast cancer: final analysis of Canadian Cancer Trials Group IND.213.

scientific article

A randomized phase-II study of BB-10010 (macrophage inflammatory protein- 1alpha) in patients with advanced breast cancer receiving 5-fluorouracil, adriamycin, and cyclophosphamide chemotherapy

scientific article published on 01 September 1998

A randomized trial comparing vascular access strategies for patients receiving chemotherapy with trastuzumab for early-stage breast cancer

scientific article published on 30 January 2020

A randomized trial exploring the biomarker effects of neoadjuvant sequential treatment with exemestane and anastrozole in post-menopausal women with hormone receptor-positive breast cancer

scientific article published in January 2010

A randomized, double-blind, phase II, exploratory trial evaluating the palliative benefit of either continuing pamidronate or switching to zoledronic acid in patients with high-risk bone metastases from breast cancer

scientific article published on 7 December 2015

A randomized, double-blind, window of opportunity trial evaluating the effects of chloroquine in breast cancer patients

scientific article published on 07 August 2019

A randomized, phase III trial exploring the effects of neoadjuvant sequential treatment with steroidal (exemestane) and nonsteroidal (anastrozole) aromatase inhibitors on biomarkers in postmenopausal women with hormone receptor-positive locally adva

A scoping review characterizing "Choosing Wisely®" recommendations for breast cancer management

scientific article published on 06 November 2020

A simple approach for eliminating spam

scientific article published on 18 February 2016

A systematic review of dosing frequency with bone-targeted agents for patients with bone metastases from breast cancer

scientific article

ABCC5 supports osteoclast formation and promotes breast cancer metastasis to bone.

scientific article

Acquisition of metastatic tissue from patients with bone metastases from breast cancer.

scientific article published on 27 November 2010

Adjuvant bisphosphonate therapy for breast cancer patients: Standard of care or future direction?

scientific article published on 23 March 2009

Adjuvant bisphosphonate treatment for breast cancer: Where are we heading and can the pre-clinical literature help us get there?

scientific article

Adjuvant bisphosphonate treatment for breast cancer: why did something so elegant become so complicated?

scientific article published on 05 May 2012

Adjuvant trastuzumab for breast cancer

scientific article published on November 2005

Altered calcium metabolism in patients on long-term bisphosphonate therapy for metastatic breast cancer.

scientific article published in July 2009

Amenorrhoea, menopause, and endocrine therapy for breast cancer

scientific article published on 3 December 2009

An interdisciplinary and collaborative initiative in palliative care research

scientific article

Applying Serum Cytokine Levels to Predict Pain Severity in Cancer Patients

scientific article published on 07 February 2020

Approach to inflammatory breast cancer.

scientific article published on January 2009

Aprepitant versus dexamethasone to prevent delayed emesis after chemotherapy

scientific article published on 09 June 2014

Are Estring® and Vagifem® equally effective and safe for the treatment of urogenital atrophy in breast cancer patients on aromatase inhibitor therapy?

scientific article published on 12 July 2012

Are Physicians Choosing Wisely When Imaging for Distant Metastases in Women With Operable Breast Cancer?

scientific article

Are adjuvant bisphosphonates now standard of care of women with early stage breast cancer? A debate from the Canadian Bone and the Oncologist New Updates meeting

scientific article

Aromatase inhibitors in the adjuvant setting: bringing the gold to a standard?

scientific article published on June 2004

Assessment of therapeutic response in patients with metastatic bone disease

scientific article published in October 2004

Automated CT-based analysis to detect changes in the prevalence of lytic bone metastases from breast cancer.

scientific article published on 22 October 2008

Baseline radiological staging in primary breast cancer: impact of educational interventions on adherence to published guidelines

scientific article published on August 2007

Benefits and harms of medical cannabis: a scoping review of systematic reviews

scientific article published on 10 December 2019

Bevacizumab for advanced breast cancer: hope, hype, and hundreds of headlines

scientific article published on 26 September 2013

Biopsy confirmation of metastatic breast cancer: interim results of a prospective biopsy study

Bisphosphonate use for the management of breast cancer patients with bone metastases: a survey of Canadian Medical Oncologists

scientific article published on 21 August 2004

Bone-Targeted Agents for the Management of Breast Cancer Patients with Bone Metastases

scientific article published on 19 August 2013

Bone-targeted agent use for bone metastases from breast cancer and prostate cancer: A patient survey

scientific article

Bone-targeted agents and skeletal-related events in breast cancer patients with bone metastases: the state of the art

scientific article

Bone-targeted agents in the treatment of bone metastases: RANK outsider or new kid on the block?

scientific article

Bone-targeted therapy for metastatic breast cancer-Where do we go from here? A commentary from the BONUS 8 meeting.

scientific article

Bone-targeted therapy use in patients with bone metastases from lung cancer: A systematic review of randomized controlled trials.

scientific article

Breast cancer and bone metastases: the association of axial skeleton MRI findings with skeletal-related events and survival

scientific article published on 10 July 2014

Breast cancer in pregnancy: are taxanes safe?

scientific article published in March 2006

Breast cancer risk following irradiation for Hodgkin's disease

scientific article

Buparlisib plus fulvestrant versus placebo plus fulvestrant for postmenopausal, hormone receptor-positive, human epidermal growth factor receptor 2-negative, advanced breast cancer: Overall survival results from BELLE-2.

scientific article

Buparlisib plus fulvestrant versus placebo plus fulvestrant in postmenopausal, hormone receptor-positive, HER2-negative, advanced breast cancer (BELLE-2): a randomised, double-blind, placebo-controlled, phase 3 trial.

scientific article

CCN3 impairs osteoblast and stimulates osteoclast differentiation to favor breast cancer metastasis to bone

scientific article

Can bone markers guide more effective treatment of bone metastases from breast cancer?

scientific article

Can the referring surgeon enhance accrual of breast cancer patients to medical and radiation oncology trials? The ENHANCE study

scientific article published on 09 June 2016

Canada follows the US in the rise of bilateral mastectomies for unilateral breast cancer: a 23-year population cohort study

scientific article published on 30 October 2020

Canadian initiatives for locally advanced breast cancer research and treatment: inaugural meeting of the Canadian Consortium for LABC

Cardiac management during adjuvant trastuzumab therapy: recommendations of the Canadian Trastuzumab Working Group.

scientific article

Caught in the middle: case study of a brachial (sentry) lymph node recurrence after resection and locoregional breast radiotherapy.

scientific article

Changes in estrogen receptor, progesterone receptor and Her-2/neu status with time: discordance rates between primary and metastatic breast cancer.

scientific article published on May 2009

Chemotherapy in the oldest old: The feasibility of delivering cytotoxic therapy to patients 80 years old and older

scientific article published on 13 August 2015

Chemotherapy-Induced Nausea and Vomiting: Time for More Emphasis on Nausea?

scientific article

Chemotherapy-induced anaemia during adjuvant treatment for breast cancer: development of a prediction model.

scientific article published in November 2005

Chemotherapy-induced nausea and vomiting in breast cancer patients: a prospective observational study

scientific article published in September 2007

Chemotherapy: dose-dense treatment for triple-negative breast cancer

scientific article published on 01 February 2010

Choice of study endpoint significantly impacts the results of breast cancer trials evaluating chemotherapy-induced nausea and vomiting

scientific article published on 5 January 2016

Citrobacter freundii and fatal neutropenic enterocolitis following adjuvant chemotherapy for breast cancer

scientific article published on January 1997

Claudin-2 promotes breast cancer liver metastasis by facilitating tumor cell interactions with hepatocytes

scientific article

Clinical practice guidelines and consensus statements in oncology--an assessment of their methodological quality.

scientific article

Cognitive Function, Fatigue, and Menopausal Symptoms in Women Receiving Adjuvant Chemotherapy for Breast Cancer ⬇️

scientific article published on November 15, 2003

Comparing Interventions for Management of Hot Flashes in Patients With Breast and Prostate Cancer: A Systematic Review With Meta-Analyses

scientific article published on 01 July 2020

Comparing the results of bisphosphonate use in clinical trials with actual practice: a case of apples and oranges?

scientific article

Comparison of physical interventions, behavioral interventions, natural health products, and pharmacologics to manage hot flashes in patients with breast or prostate cancer: protocol for a systematic review incorporating network meta-analyses

scientific article

Complementary and alternative medicine use is associated with an increased perception of breast cancer risk and death

scientific article published in March 2005

Concurrent chemoradiotherapy for locally advanced breast cancer-time for a new paradigm?

scientific article

Contraceptive use by women receiving chemotherapy for breast cancer

Correlation of baseline biomarkers with clinical outcomes and response to fulvestrant with vandetanib or placebo in patients with bone predominant metastatic breast cancer: An OCOG ZAMBONEY sub-study

scientific article

Cost analysis of using Magee scores as a surrogate of Oncotype DX for adjuvant treatment decisions in women with early breast cancer

scientific article published on 09 July 2019

Cost implications of unwarranted imaging for distant metastasis in women with early-stage breast cancer in Ontario

scientific article published on 29 February 2016

Creating a pragmatic trials program for breast cancer patients: Rethinking Clinical Trials (REaCT)

scientific article published on 24 May 2019

De-Escalation of Bone-Modifying Agents in Patients With Bone Metastases: The Best of Times and the Worst of Times?

scientific article published on 01 August 2018

De-escalated administration of bone-targeted agents in patients with breast and prostate cancer-A survey of Canadian oncologists.

scientific article

De-escalation of bone-modifying agents in patients with bone metastases from breast cancer: a systematic review and meta-analysis

scientific article published on 11 May 2019

De-escalation of bone-targeted agents for metastatic prostate cancer

scientific article published on 18 February 2016

Defining optimal control of chemotherapy-induced nausea and vomiting-based on patients' experience.

scientific article published on 25 June 2015

Defining ovarian failure in amenorrheic young breast cancer patients.

scientific article published on 07 July 2010

Definition and consequences of locally advanced breast cancer.

scientific article published on March 2014

Detection of PIK3CA Mutations in Breast Cancer Bone Metastases

scientific article published on 30 August 2012

Developing a prediction model for benefit from fulvestrant in heavily pretreated metastatic breast cancer patients.

scientific article published on 23 June 2009

Discordance between hormone receptor profile of primary breast cancer and metastatic bone disease: should bone marrow biopsy be considered a standard of care?

scientific article published on 23 June 2009

Discordance between receptor status in primary and metastatic breast cancer: an exploratory study of bone and bone marrow biopsies

scientific article published on 27 September 2008

Do alternative methods of measuring tumor size, including consideration of multicentric/multifocal disease, enhance prognostic information beyond TNM staging in women with early stage breast cancer: an analysis of the NCIC CTG MA.5 and MA.12 clinica

scientific article

Do physicians follow systemic treatment and funding policy guidelines?

scientific article published in March 2004

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

scientific article published on 18 March 2009

Does estrogen play a role in response to adjuvant bone-targeted therapies?

scientific article

Does integration of Magee equations into routine clinical practice affect whether oncologists order the Oncotype DX test? A prospective randomized trial

scientific article published on 23 January 2019

Does treatment at the time of locoregional failure of breast cancer alter prognosis?

scientific article

Dosing Strategies of Bone-Targeting Agents

scientific article published on 01 November 2015

Dual blockade of HER2 - twice as good or twice as toxic?

scientific article published on 28 June 2012

Effects of Celecoxib and Low-dose Aspirin on Outcomes in Adjuvant Aromatase Inhibitor-Treated Patients: CCTG MA.27.

scientific article published on 15 March 2018

Effects of de-escalated bisphosphonate therapy on bone turnover biomarkers in breast cancer patients with bone metastases

scientific article

Effects of de-escalated bisphosphonate therapy on the Functional Assessment of Cancer Therapy-Bone Pain, Brief Pain Inventory and bone biomarkers

scientific article

Effects on bone resorption markers of continuing pamidronate or switching to zoledronic acid in patients with high risk bone metastases from breast cancer

scientific article published on 8 November 2017

End-of-life care in Canada

scientific article

Enhancing accrual to chemotherapy trials for patients with early stage triple-negative breast cancer: a survey of physicians and patients.

scientific article published on 27 January 2017

Erratum to: The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer

scientific article published on 16 March 2006

Erratum to: platinum-based chemotherapy in triple-negative advanced breast cancer

scientific article published on 01 April 2015

Estrogen, progesterone, and HER2/neu receptor discordance between primary and metastatic breast tumours-a review

scientific article published on 12 July 2016

Evaluating the feasibility of performing window of opportunity trials in breast cancer.

scientific article

Evolution of sites of recurrence after early breast cancer over the last 20 years: implications for patient care and future research

scientific article published on 17 May 2013

Examination of the mechanisms of osteolysis in patients with metastatic breast cancer.

scientific article published on May 2009

Excision of the primary tumour in patients with metastatic breast cancer: a clinical dilemma

scientific article

Exploring reasons for overuse of contralateral prophylactic mastectomy in Canada

scientific article published on 01 August 2019

Extending neoadjuvant care through multi-disciplinary collaboration: proceedings from the fourth annual meeting of the Canadian Consortium for Locally Advanced Breast Cancer.

scientific article

External influences and priority-setting for anti-cancer agents: a case study of media coverage in adjuvant trastuzumab for breast cancer

scientific article

Feasibility of using a pragmatic trials model to compare two primary febrile neutropenia prophylaxis regimens (ciprofloxacin versus G-CSF) in patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer (REaCT-TC)

scientific article published on 11 August 2018

Filgrastim use in patients receiving chemotherapy for early-stage breast cancer-a survey of physicians and patients.

scientific article published on 6 February 2018

Filling in the gaps: reporting of concurrent supportive care therapies in breast cancer chemotherapy trials.

scientific article

First-line treatment options for patients with HER-2 negative metastatic breast cancer: the impact of modern adjuvant chemotherapy

scientific article published on July 2007

Fulvestrant for hormone-sensitive metastatic breast cancer

scientific article

Future directions for bone metastasis research - highlights from the 2015 bone and the Oncologist new updates conference (BONUS)

scientific article

Guidelines versus individualized care for the management of CINV.

scientific article

Health care strategies to promote earlier presentation of symptomatic breast cancer: perspectives of women and family physicians

scientific article

Helping expectations become reality for dying cancer patients

scientific article published on July 2006

Heterogeneity of O6-alkylguanine DNA-alkyltransferase expression in human breast tumours

scientific article published on June 2002

Histomorphometric and microarchitectural analyses using the 2 mm bone marrow trephine in metastatic breast cancer patients-preliminary results

scientific article

Holiday reading: The Mayan Doomsday's effect on survival outcomes in clinical trials.

scientific article published on December 2012

Hormonal risk factors for breast cancer: identification, chemoprevention, and other intervention strategies

scientific article

Identification of genomic signatures in circulating tumor cells from breast cancer

scientific article published on 12 January 2015

Identifying an optimal antiemetic regimen for patients receiving anthracycline and cyclophosphamide-based chemotherapy for breast cancer--an inspection of the evidence base informing clinical decision-making

scientific article published on 30 September 2015

Identifying menopause in breast cancer patients: considerations and implications

scientific article published on 24 October 2006

Imaging for distant metastases in women with early-stage breast cancer: a population-based cohort study.

scientific article

Imaging for metastatic disease in patients with newly diagnosed breast cancer: are doctor's perceptions in keeping with the guidelines?

scientific article published on 14 October 2014

Immune therapy for breast cancer in 2010-hype or hope?

scientific article

Incidence and consequences of bone metastases in lung cancer patients

scientific article

Incidence of taxane-induced pain and distress in patients receiving chemotherapy for early-stage breast cancer: a retrospective, outcomes-based survey

scientific article

Incidence, consequences and treatment of bone metastases in breast cancer patients-Experience from a single cancer centre

scientific article

Inhibition of EGFR, HER2, and HER3 signaling with AZD8931 in combination with anastrozole as an anticancer approach: Phase II randomized study in women with endocrine-therapy-naïve advanced breast cancer

scientific article

Insulin-lowering effects of metformin in women with early breast cancer

scientific article

Invasive Pleomorphic Lobular Carcinoma of the Breast: Pathologic, Clinical, and Therapeutic Considerations

scientific article published on 22 June 2015

Investigating the discernible and distinct effects of platinum-based chemotherapy regimens for metastatic triple-negative breast cancer on time to progression

scientific article published on 07 January 2014

Is This Conference for Real? Navigating Presumed Predatory Conference Invitations.

scientific article published on 14 June 2017

Is there a role for oral or intravenous ascorbate (vitamin C) in treating patients with cancer? A systematic review

scientific article

Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast

scientific article

Lapatinib and HER2 status: results of a meta-analysis of randomized phase III trials in metastatic breast cancer.

scientific article published on 25 January 2010

Letters to the editor

scientific article published on 01 April 1997

Locoregionally recurrent breast cancer: incidence, risk factors and survival

scientific article

Long-term benefits versus side-effects from bone-targeted therapies for cancer patients: minimizing risk while maximizing benefits.

scientific article

Long-term impact of bone-modifying agents for the treatment of bone metastases: a systematic review

scientific article published on 13 June 2020

Lost in transition? Thoughts on retirement--"will you still need me, will you still feed me, when i'm sixty-four?".

scientific article published on 16 September 2013

Macrophage inflammatory protein 1alpha attenuates the toxic effects of temozolomide in human bone marrow granulocyte-macrophage colony-forming cells.

scientific article

Management of Epidermal Growth Factor Receptor Inhibitor-Induced Hypomagnesemia: A Systematic Review.

scientific article published on 13 February 2016

Management of the menopause in cancer survivors

scientific article

Management of urogenital atrophy in breast cancer patients: a systematic review of available evidence from randomized trials.

scientific article published on 24 May 2015

Measuring the impact of guideline-based antiemetic therapy on nausea and vomiting control in breast cancer patients with multiple risk factors

scientific article published on 17 September 2015

Mechanisms and pathways of bone metastasis: challenges and pitfalls of performing molecular research on patient samples.

scientific article

Medical oncology: Zoledronic acid for breast cancer therapy-induced bone loss

scientific article published in April 2010

Menstrual cycle associated changes in hormone-related gene expression in oestrogen receptor positive breast cancer

scientific article published on 15 November 2019

Molecular changes in premenopausal oestrogen receptor-positive primary breast cancer in Vietnamese women after oophorectomy

scientific article published on 27 November 2017

More about osteonecrosis

scientific article published on 01 April 2011

Neoadjuvant endocrine therapy and window of opportunity trials: new standards in the treatment of breast cancer?

scientific article

Neoadjuvant endocrine treatment for breast cancer: from bedside to bench and back again?

scientific article published on February 2014

Novel Methodology for Comparing Standard-of-Care Interventions in Patients With Cancer.

scientific article

O6-(4-bromothenyl)guanine reverses temozolomide resistance in human breast tumour MCF-7 cells and xenografts

scientific article published on November 2005

Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study

scientific article published on 19 August 2011

Oncologist heal thyself: hallmarks of happiness

scientific article published on December 2015

Optimal Management of Leptomeningeal Carcinomatosis in Breast Cancer Patients-A Systematic Review.

scientific article

Optimal primary febrile neutropenia prophylaxis for patients receiving docetaxel-cyclophosphamide chemotherapy for breast cancer: a systematic review

scientific article

Optimal sequence of adjuvant endocrine and radiation therapy in early-stage breast cancer - A systematic review

scholarly article by S.F. McGee et al published September 2018 in Cancer Treatment Reviews

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review

article published in 2018

Optimal vascular access strategies for patients receiving chemotherapy for early-stage breast cancer: a systematic review

Optimisation of steroid prophylaxis schedules in breast cancer patients receiving docetaxel chemotherapy-a survey of health care providers and patients.

scientific article published on 3 May 2015

Optimising the use of bone-targeted agents in patients with metastatic cancers: a practical guide for medical oncologists

scientific article published on 22 July 2011

Optimizing the management of HER2-positive early breast cancer: the clinical reality

scientific article

Optimizing vascular access for patients receiving intravenous systemic therapy for early-stage breast cancer-a survey of oncology nurses and physicians

Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists.

scientific article

Overcoming endocrine resistance in breast cancer: are signal transduction inhibitors the answer?

scientific article published on 22 May 2007

PDK1-Dependent Metabolic Reprogramming Dictates Metastatic Potential in Breast Cancer

scientific article published on 9 September 2015

Pain outcomes in patients with advanced breast cancer and bone metastases: results from a randomized, double-blind study of denosumab and zoledronic acid

journal article published in 2013

Palliative treatment of painful bone metastases with MR imaging--guided focused ultrasound

scientific article published on 11 August 2008

Patient decision aid for contralateral prophylactic mastectomy for use in the consultation: a feasibility study

Patient perceptions and expectations regarding imaging for metastatic disease in early stage breast cancer

scientific article published on 05 April 2014

Patients' and health care professionals' evaluation of health-related quality of life issues in bone metastases

scientific article published on 25 July 2009

Pattern of care at the end of life: does age make a difference?

scientific article published on 01 April 2005

Pegylated liposomal doxorubicin and trastuzumab in HER-2 overexpressing metastatic breast cancer: a multicenter phase II trial

scientific article published on 08 May 2006

Perceptions of vascular access for intravenous systemic therapy and risk factors for lymphedema in early-stage breast cancer-a patient survey

Perivascular M2 Macrophages Stimulate Tumor Relapse after Chemotherapy

scientific article published on 12 August 2015

Perspectives on the future of bisphosphonate use in breast cancer patients

scientific article published in October 2004

Pharmacokinetic, biochemical and clinical effects of dimethyltriazenoimidazole-4-carboxamide-bischloroethylnitrosourea combination therapy in patients with advanced breast cancer

scientific article

Pharmacotherapy of bone metastases in breast cancer patients

scientific article published on April 2008

Pharmacotherapy of bone metastases in breast cancer patients--an update.

scientific article published on 28 March 2014

Phase I trial of the oral PARP inhibitor olaparib in combination with paclitaxel for first- or second-line treatment of patients with metastatic triple-negative breast cancer.

scientific article published on January 2013

Phase I/II trial of metronomic chemotherapy with daily dalteparin and cyclophosphamide, twice-weekly methotrexate, and daily prednisone as therapy for metastatic breast cancer using vascular endothelial growth factor and soluble vascular endothelial

scientific article published on 21 December 2009

Phase II multicenter trial of anthracycline rechallenge with pegylated liposomal doxorubicin plus cyclophosphamide for first-line therapy of metastatic breast cancer previously treated with adjuvant anthracyclines

scientific article published on 26 October 2009

Phase II trial evaluating the palliative benefit of second-line zoledronic acid in breast cancer patients with either a skeletal-related event or progressive bone metastases despite first-line bisphosphonate therapy

scientific article published on 25 September 2006

Phase II, double-blind, randomized trial of capecitabine plus enzastaurin versus capecitabine plus placebo in patients with metastatic or recurrent breast cancer after prior anthracycline and taxane therapy ⬇️

scientific article published on 03 September 2010

Phase III randomized trial of bisphosphonates as adjuvant therapy in breast cancer: S0307

scientific article published on 31 October 2019

Phase III trial of gemcitabine and carboplatin versus mitomycin, ifosfamide, and cisplatin or mitomycin, vinblastine, and cisplatin in patients with advanced nonsmall cell lung carcinoma

scientific article published in August 2003

Phase ii trial of a metronomic schedule of docetaxel and capecitabine with concurrent celecoxib in patients with prior anthracycline exposure for metastatic breast cancer.

scientific article published in April 2012

Physician "out of office" alert: does it work?

scientific article published on 27 June 2017

Physician Survey of Timing of Adjuvant Endocrine Therapy Relative to Radiotherapy in Early Stage Breast Cancer Patients

scientific article published on 04 September 2018

Platinum-based chemotherapy in triple-negative advanced breast cancer

scientific article published on 08 July 2014

Poor outcomes after venous thromboembolism in cancer patients: It's time to change practice

scientific article published on 02 June 2018

Population Trends in Lobular Carcinoma of the Breast: The Ontario Experience

scientific article published on 28 July 2020

Practical update for the use of bone-targeted agents in patients with bone metastases from metastatic breast cancer or castration-resistant prostate cancer

scientific article published on 01 August 2020

Pre-menopausal breast cancer and aromatase inhibitors: Treating a new generation of women

scientific article

Predatory Invitations from Journals: More Than Just a Nuisance?

scientific article published on 10 February 2017

Predicting benefit from fulvestrant in pretreated metastatic breast cancer patients.

scientific article published on 24 June 2009

Preference weights for chemotherapy side effects from the perspective of women with breast cancer.

scientific article

Prevalence and severity of urogenital symptoms in postmenopausal women receiving endocrine therapy for breast cancer.

scientific article

Prevalence of overt metastases in locally advanced breast cancer.

scientific article published on June 2008

Prevention and management of bone metastases in lung cancer: a review

scientific article published on February 2009

Primary Febrile Neutropenia Prophylaxis for Patients Who Receive FEC-D Chemotherapy for Breast Cancer: A Systematic Review

scientific article published on 21 April 2017

Primary endocrine therapy as an approach for patients with localized breast cancer deemed not to be surgical candidates

scientific article published on March 2014

Prospective randomised controlled trial using the REthinking Clinical Trials (REaCT) platform and National Surgical Quality Improvement Program (NSQIP) to compare no preparation versus preoperative oral antibiotics alone for surgical site infection

scientific article published on 09 July 2020

Prospective study evaluating the impact of tissue confirmation of metastatic disease in patients with breast cancer

scientific article

Prospective validation of a prediction tool for identifying patients at high risk for chemotherapy-induced nausea and vomiting

scientific article published in March 2013

Prospective validation of risk prediction indexes for acute and delayed chemotherapy-induced nausea and vomiting.

scientific article

Publishing clinical research: ten pearls for oncology trainees and junior oncologists.

scientific article

Quality of life in patients with brain metastases using the EORTC QLQ-BN20+2 and QLQ-C15-PAL.

scientific article published on 13 December 2011

Quantitative characterization of metastatic disease in the spine. Part II. Histogram-based analyses.

scientific article published in August 2007

Radiological changes following second-line zoledronic acid treatment in breast cancer patients with bone metastases

scientific article published on 6 March 2009

Randomised feasibility trial to compare three standard of care chemotherapy regimens for early stage triple-negative breast cancer (REaCT-TNBC trial)

scientific article published in PLoS ONE

Randomised phase II trial of pegylated liposomal doxorubicin (DOXIL/CAELYX) versus doxorubicin in the treatment of advanced or metastatic soft tissue sarcoma: a study by the EORTC Soft Tissue and Bone Sarcoma Group

scientific article published in May 2001

Randomised, phase II, placebo-controlled, trial of fulvestrant plus vandetanib in postmenopausal women with bone only or bone predominant, hormone-receptor-positive metastatic breast cancer (MBC): the OCOG ZAMBONEY study.

scientific article published on 13 June 2014

Randomized feasibility study of de-escalated (every 12 wk) versus standard (every 3 to 4 wk) intravenous pamidronate in women with low-risk bone metastases from breast cancer

scientific article

Randomized phase II study comparing two schedules of everolimus in patients with recurrent/metastatic breast cancer: NCIC Clinical Trials Group IND.163.

scientific article published on 17 August 2009

Randomized window of opportunity trial evaluating high-dose vitamin D in breast cancer patients

scientific article published on 09 August 2019

Real-world practice patterns and attitudes towards de-escalation of bone-modifying agents in patients with bone metastases from breast and prostate cancer: A physician survey

scientific article published on 10 November 2020

Recent developments in bisphosphonates for patients with metastatic breast cancer

scientific article

Renal cell carcinoma bone metastases: clinical advances

scientific article published in March 2010

Reply to T.J. Powles et al

scientific article published on 27 June 2017

Rethinking end-points for bone-targeted therapy in advanced cancer

scientific article published on 11 June 2016

Review of recent trials of chemotherapy for advanced breast cancer: studies excluding taxanes

scientific article published on November 1997

Risk Model-Guided Antiemetic Prophylaxis vs Physician's Choice in Patients Receiving Chemotherapy for Early-Stage Breast Cancer: A Randomized Clinical Trial

scientific article

Risk factors for bisphosphonate-associated osteonecrosis of the jaw in the prospective randomized trial of adjuvant bisphosphonates for early-stage breast cancer (SWOG 0307)

scientific article published on 15 September 2020

Risk prediction models for chemotherapy-induced nausea and vomiting: almost ready for prime time?

scientific article published on 29 January 2014

Role of Bone-Modifying Agents in Metastatic Breast Cancer: An American Society of Clinical Oncology-Cancer Care Ontario Focused Guideline Update

scientific article published on 16 October 2017

Searching for perfection: further progress in management of chemotherapy-induced nausea and vomiting-CME information

scientific article published on 19 March 2018

Selecting Patients for Oncotype DX Testing Using Standard Clinicopathologic Information

scientific article published on 22 August 2019

Sexuality in women receiving chemotherapy for breast cancer ⬇️

scientific article published on 01 June 1997

Should a biopsy be recommended to confirm metastatic disease in women with breast cancer?

scientific article published in October 2009

Should de-escalation of bone-targeting agents be standard of care for patients with bone metastases from breast cancer? A systematic review and meta-analysis

scientific article published on 28 June 2015

Should de-escalation of bone-targeting agents be standard of care?

scientific article published on 01 May 2018

Should oral bisphosphonates be standard of care in women with early breast cancer?

scientific article

Should urogenital atrophy in breast cancer survivors be treated with topical estrogens?

scientific article published on March 2008

Skeletal-related events (SREs) in breast cancer patients with bone metastases treated in the nontrial setting

scientific article

Strategies for obtaining bone biopsy specimens from breast cancer patients - Past experience and future directions

scientific article published on 07 July 2016

Survival differences observed in metastatic breast cancer patients treated with capecitabine when compared with vinorelbine after pretreatment with anthracycline and taxane.

scientific article published on June 2007

Survival outcomes for patients with metastatic triple-negative breast cancer: implications for clinical practice and trial design

scientific article published on February 2009

Surviving Surveys

article published in 2015

Switching breast cancer patients with progressive bone metastases to third-generation bisphosphonates: measuring impact using the Functional Assessment of Cancer Therapy-Bone Pain

scientific article

Systemic treatment approaches in her2-negative advanced breast cancer-guidance on the guidelines

scientific article

Systemic treatment of bone metastases from breast cancer: is it all that it's cracked up to be?

scientific article published on 01 July 2005

Tamoxifen ("Nolvadex"): a review.

scientific article

Taxane acute pain syndrome (TAPS) in patients receiving chemotherapy for breast or prostate cancer: a prospective multi-center study.

scientific article published on 21 March 2018

Taxane acute pain syndrome (TAPS) in patients receiving taxane-based chemotherapy for breast cancer-a systematic review.

scientific article

The European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire for patients with bone metastases: the EORTC QLQ-BM22.

scientific article published on 25 December 2008

The ZOOM trial: more boon than doom?

scientific article published on 01 September 2013

The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting

scientific article

The effect of melatonin on sleep and quality of life in patients with advanced breast cancer

scientific article published on 11 August 2015

The global cancer epidemic: opportunities for Canada in low- and middle-income countries

scientific article

The impact of endocrine therapy on sexual dysfunction in postmenopausal women with early stage breast cancer: encouraging results from a prospective study

scientific article published on 14 August 2013

The importance of greater speed in drug development for advanced malignancies.

scientific article published on 30 March 2018

The incidence and clinical impact of bone metastases in non-small cell lung cancer.

scientific article published on 11 May 2015

The latest is the greatest? Results of a structured lecture about aromatase inhibitor use for breast cancer

scientific article

The role of HER2-targeted therapies in women with HER2-overexpressing metastatic breast cancer

scientific article

The role of neoadjuvant (HER)2-targeted therapies in (HER)2-overexpressing breast cancers.

scientific article published on September 2009

The symptom appraisal of breast cancer in the context of an intimate relationship

scientific article published on 17 March 2011

The use of complementary and alternative medicines among patients with locally advanced breast cancer--a descriptive study

scientific article

The value of dose intensification of standard chemotherapy for advanced breast cancer using colony-stimulating factors alone

scientific article published on 01 June 1998

Third-party online surveys-science, selling, or sugging?

scientific article published on June 2015

Thoughts on Jim Flaherty. When should physicians retire?

scientific article

Time to put an end to the "one size fits all" approach to bisphosphonate use in patients with metastatic breast cancer?

scientific article

Tissue confirmation of disease recurrence in breast cancer patients: pooled analysis of multi-centre, multi-disciplinary prospective studies.

scientific article

Too much, too little, too late to start again? Assessing the efficacy of bisphosphonates in patients with bone metastases from breast cancer

scientific article

Training the trainer: five practical considerations for your first five years in practice

scientific article published on 13 April 2016

Transfer of follow-up care to family physicians for early-stage breast cancer

scientific article

Trastuzumab after primary treatment for early stage HER2-positive breast cancer reduces recurrence

scientific article published on 06 March 2006

Travelling on parallel tracks: patient and physician perspectives on why women delay seeking care for breast cancer symptoms

scientific article published on 01 January 2012

Treatment choices for patients with invasive lobular breast cancer: a doctor survey

scientific article published on 9 June 2015

Treatment for locally advanced breast cancer

scientific article published on 01 March 2014

Treatment of locally advanced breast cancer

Treatment of taxane acute pain syndrome (TAPS) in cancer patients receiving taxane-based chemotherapy-a systematic review.

scientific article published on 19 September 2015

Treatment outcome and prognostic factors for relapse after high-dose chemotherapy and peripheral blood stem cell rescue for patients with poor risk high grade non-Hodgkin's lymphoma

scientific article published in August 1999

Unnecessary variation in practice: how to improve cancer care through pragmatic trials

Urinary N-telopeptide is a rapid predictor of response to and palliative benefit from bisphosphonate therapy in patients with metastatic breast cancer

scientific article published on September 2007

Use and delivery of granulocyte colony-stimulating factor in breast cancer patients receiving neoadjuvant or adjuvant chemotherapy-single-centre experience

scientific article

Use of Adjuvant Bisphosphonates and Other Bone-Modifying Agents in Breast Cancer: A Cancer Care Ontario and American Society of Clinical Oncology Clinical Practice Guideline.

scientific article published on 6 March 2017

Use of Preoperative Magnetic Resonance Imaging for Breast Cancer: A Canadian Population-Based Study

scientific article

Use of conjoint analysis to assess breast cancer patient preferences for chemotherapy side effects.

scientific article published on 28 January 2014

Using aromatase inhibitors in the neoadjuvant setting: evolution or revolution?

scientific article published on 18 November 2004

Utilization of palliative radiotherapy for breast cancer patients with bone metastases treated with bisphosphonates?Toronto Sunnybrook Regional Cancer Centre experience ⬇️

scientific article published on October 24, 2003

Vascular endothelial growth factor activity after switching of bisphosphonate treatment for metastatic breast cancer.

scientific article published in May 2009

What is the best chemotherapy treatment option for anthracycline and taxane pretreated metastatic breast cancer?

scientific article published in September 2005

What we learned in kindergarten: five tips for collaboration in oncology.

scientific article published on 25 October 2017

Why "Reply All" Can Push All the Wrong Buttons

scientific article published on 04 June 2019

Why women delay seeking assistance for locally advanced breast cancer.

scientific article published in January 2010

Will oncologists applaud the Paris Accord? Time to rethink global mega-conferences

scientific article published on 12 August 2016

Paulina is supported by:

About Paulina

Help